European Biotech Acquisition Corp.
European Biotech Acquisition Corp. (EBAC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ebac · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for European Biotech Acquisition Corp. (EBAC) measures how much investors pay for each dollar of the company's trailing earnings. EBAC's current PE ratio of 40.73x is calculated by dividing its stock price of $11.19 by its TTM earnings per share of $0.27. +37.8% elevated vs 5Y avg 29.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2021 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
European Biotech Acquisition Corp.You EBAC | $184M | 40.73x | +67.0% | $0.27 |
 AP Acquisition Corp. APCA | $179M | 64.76x | +165.6% | $0.17 |
 Bridgetown Holdings Limited BTWN | $184M | N/A | — | — |
 Direxion Daily COIN Bull 2X ETF CONX | $1M | 1.21x | -95.0% | $19.96 |
 G Squared Ascend II Inc. GSQB | $188M | 13.02x | -46.6% | $0.78 |
 Parabellum Acquisition Corp. PRBM | $179M | 6.37x | -73.9% | $1.53 |
 SK Growth Opportunities Corporation SKGR | $180M | 36.58x | +50.0% | $0.32 |
Industry Average 5 peers with valid PE | — | 24.39x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 36.77x | $0.27 | +64.6% | |
2021-12-31 FY2021 | 22.34x | $0.43 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for European Biotech Acquisition Corp. (EBAC) measures how much investors pay for each dollar of the company's trailing earnings. EBAC's current PE ratio of 40.73x is calculated by dividing its stock price of $11.19 by its TTM earnings per share of $0.27.
Frequently asked questions
EBAC pe ratio · 6 questionsEBAC's current PE ratio is 40.73x as of 2026-06-09, based on a stock price of $11.19 and TTM EPS of $0.27. Data sourced from Financial Modeling Prep via EBAC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · European Biotech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09